Moreover, previous studies demonstrated that PGE2 was necessary for S100A8 expression and found that prostanoid receptor antagonists inhibited the PGE2-mediated increase in S100A8 expression in prostate cancer cells and macrophage [29, 30]. This evidence concerns the gene S100A8 and prostate carcinoma.